| scholarly article | Q13442814 |
| P2093 | author name string | Xuan Ge | |
| Yu Wang | |||
| Aimin Xu | |||
| Xiaoyan Hui | |||
| Cheng Chen | |||
| Karen S L Lam | |||
| P2860 | cites work | Regulation of pp90rsk phosphorylation and S6 phosphotransferase activity in Swiss 3T3 cells by growth factor-, phorbol ester-, and cyclic AMP-mediated signal transduction | Q36687724 |
| Mini-review: endocrine actions of fibroblast growth factor 19. | Q37052076 | ||
| Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity | Q37328872 | ||
| Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 | ||
| Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects | Q38351110 | ||
| Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. | Q39581682 | ||
| Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. | Q40239037 | ||
| Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. | Q40526751 | ||
| Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry | Q40976467 | ||
| Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes | Q41910885 | ||
| FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model | Q42552463 | ||
| FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity | Q42813458 | ||
| The role of insulin in activation of two enhancers in the mouse GLUT1 gene | Q42832486 | ||
| Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling | Q42834234 | ||
| Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride | Q42950501 | ||
| Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 | ||
| Insulin-stimulated glucose transport minireview series | Q45083262 | ||
| Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans | Q46770146 | ||
| Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. | Q51421300 | ||
| AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5 | Q24306179 | ||
| betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c | Q24306279 | ||
| Different roles of N- and C- termini in the functional activity of FGF21 | Q24312210 | ||
| Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 | Q24318639 | ||
| FGF-21 as a novel metabolic regulator | Q24523933 | ||
| Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase | Q24564046 | ||
| Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway | Q24607012 | ||
| Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State | Q24625976 | ||
| Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice | Q24642546 | ||
| FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response | Q24653481 | ||
| BetaKlotho is required for metabolic activity of fibroblast growth factor 21 | Q24681531 | ||
| Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members | Q24683254 | ||
| Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 | ||
| c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells | Q33606245 | ||
| FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation | Q33648263 | ||
| Relevant use of Klotho in FGF19 subfamily signaling system in vivo | Q33667883 | ||
| Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. | Q33762194 | ||
| 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle | Q33869428 | ||
| Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats | Q33930333 | ||
| Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). | Q34069794 | ||
| The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. | Q34577053 | ||
| Elk-1 can recruit SRF to form a ternary complex upon the serum response element | Q34593714 | ||
| Thermogenic activation induces FGF21 expression and release in brown adipose tissue. | Q34787051 | ||
| Fibroblast growth factor 21 corrects obesity in mice | Q34805555 | ||
| Mitogen-activated protein kinases: versatile transducers for cell signaling | Q35231791 | ||
| The serum response element | Q35557503 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adipocyte | Q357519 |
| P304 | page(s) | 34533-34541 | |
| P577 | publication date | 2011-08-16 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes | |
| P478 | volume | 286 |
| Q33906438 | A link between hepatic glucose production and peripheral energy metabolism via hepatokines |
| Q92816040 | Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs |
| Q38027744 | Adipose tissue, hormones, and treatment of type 1 diabetes. |
| Q36224779 | Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth |
| Q57283864 | Bile acids and their effects on diabetes |
| Q37550329 | Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice |
| Q34316238 | Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. |
| Q27335000 | Browning of white adipose tissue uncouples glucose uptake from insulin signaling |
| Q47916949 | Cardiomyokines from the heart |
| Q36970160 | Circulating CTRP1 Levels in Type 2 Diabetes and Their Association with FGF21 |
| Q36500607 | Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation |
| Q104073661 | Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects |
| Q46134650 | Dnmt3a is an epigenetic mediator of adipose insulin resistance. |
| Q39115885 | Epigenetic regulation of the glucose transporter gene Slc2a1 by β-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice |
| Q64105434 | FGF21 as Modulator of Metabolism in Health and Disease |
| Q38645276 | FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes |
| Q47220838 | FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway |
| Q64975307 | FGF21 regulates insulin sensitivity following long-term chronic stress. |
| Q38794405 | Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus |
| Q39325845 | Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis. |
| Q26766528 | Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk |
| Q26772751 | Fibroblast Growth Factor Signaling in Metabolic Regulation |
| Q39017842 | Fibroblast growth factor 21 night watch: advances and uncertainties in the field |
| Q54268091 | Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway. |
| Q90212918 | Functional Implications of DNA Methylation in Adipose Biology |
| Q46420424 | Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α. |
| Q59357132 | Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21 |
| Q37251086 | High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling |
| Q28550659 | Human FGF-21 Is a Substrate of Fibroblast Activation Protein |
| Q34603941 | Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice |
| Q53807997 | Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway. |
| Q33648885 | Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells |
| Q90240789 | KLB gene polymorphism is associated with obesity and non-alcoholic fatty liver disease in the Han Chinese |
| Q35274798 | Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice |
| Q93080669 | Lyophilized Maqui (Aristotelia chilensis) Berry Induces Browning in the Subcutaneous White Adipose Tissue and Ameliorates the Insulin Resistance in High Fat Diet-Induced Obese Mice |
| Q90223120 | Metabolic Determinants of Weight Gain in Humans |
| Q37160100 | MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity |
| Q38858879 | N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway |
| Q48107382 | Pharmacokinetics, tissue distribution and excretion of FGF-21 following subcutaneous administration in rats. |
| Q35256779 | Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia |
| Q94560979 | Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands |
| Q36760335 | Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice |
| Q33847421 | Role of angiopoietin-2 in the cardioprotective effect of fibroblast growth factor 21 on ischemia/reperfusion-induced injury in H9c2 cardiomyocytes |
| Q39042458 | Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine |
| Q26753369 | The FGF21-adiponectin axis in controlling energy and vascular homeostasis |
| Q38750211 | The emerging role of fibroblast growth factor 21 in diabetic nephropathy |
| Q98238156 | The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic |
| Q92974039 | Therapeutic strategies for glucose transporter 1 deficiency syndrome |
| Q39332431 | Therapeutic value of brown adipose tissue: Correcting metabolic disease through generating healthy fat. |
| Q92524593 | Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster |
| Q50578906 | mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes. |